Trademark: 85300829
Word
APEBMET
Status
Dead
Status Code
606
Status Date
Monday, October 21, 2013
Serial Number
85300829
Mark Type
4000
Filing Date
Thursday, April 21, 2011
Published for Opposition
Tuesday, January 24, 2012
Abandoned Date
Monday, October 21, 2013

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals

Trademark Events
Oct 21, 2013
Abandonment Notice Mailed - No Use Statement Filed
Oct 21, 2013
Abandonment - No Use Statement Filed
Mar 28, 2013
Notice Of Approval Of Extension Request E-Mailed
Mar 27, 2013
Extension 2 Granted
Mar 7, 2013
Extension 2 Filed
Mar 26, 2013
Case Assigned To Intent To Use Paralegal
Mar 12, 2013
Teas Change Of Correspondence Received
Mar 7, 2013
Teas Extension Received
Aug 24, 2012
Notice Of Approval Of Extension Request Mailed
Aug 23, 2012
Extension 1 Granted
Aug 17, 2012
Extension 1 Filed
Aug 23, 2012
Case Assigned To Intent To Use Paralegal
Aug 17, 2012
Teas Extension Received
Mar 20, 2012
Noa Mailed - Sou Required From Applicant
Jan 24, 2012
Published For Opposition
Jan 4, 2012
Notice Of Publication
Dec 17, 2011
Law Office Publication Review Completed
Dec 16, 2011
Approved For Pub - Principal Register
Dec 15, 2011
Teas/Email Correspondence Entered
Dec 15, 2011
Correspondence Received In Law Office
Dec 15, 2011
Assigned To Lie
Dec 13, 2011
Teas Response To Office Action Received
Jul 1, 2011
Non-Final Action Mailed
Jun 30, 2011
Non-Final Action Written
Jun 29, 2011
Assigned To Examiner
Apr 26, 2011
New Application Office Supplied Data Entered In Tram
Apr 25, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24